Drug Trial Radar · NCT00789581
A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
Last checked: Nov 20, 2026Latest source record: Jul 2, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
614
Actual
Start
Dec 2008
Primary completion
Dec 2015
Study completion Nov 2016
Sponsor
- Lead sponsor
- SCRI Development Innovations, LLCAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Bristol-Myers Squibb
- First posted
- Nov 13, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, Phase III, open-label, multicenter study.
Conditions
- Breast Cancer
Interventions
DoxorubicinDrug
Doxorubicin 60 mg/m2
CyclophosphamideDrug
Cyclophosphamide 600 mg/m2
Ixabepilone (Ixempra)Drug
Ixabepilone 40 mg/m2
Paclitaxel (Taxol)Drug
Paclitaxel 80 mg/m2
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease-free SurvivalTime frame: up to 5.25 years (63 months)
Locations
70 sites in 2 countries. Site status is shown where the registry gives one.
Northeast Alabama Regional Medical Center
Anniston, Alabama
Cancer Center of Huntsville
Huntsville, Alabama
Clearview Cancer Institute
Huntsville, Alabama
University of Southern Alabama
Mobile, Alabama
Northeast Arkansas Clinic
Jonesboro, Arkansas
Wilshire Oncology Medical Group
La Verne, California
New Hope Cancer and Research Institute
Pomona, California
Eastern Connecticut Hematology Oncology
Norwich, Connecticut
Aventura Medical Center
Aventura, Florida
Lynn Cancer Institute
Boca Raton, Florida
Florida Cancer Care
Davie, Florida
Holy Cross Hospital
Fort Lauderdale, Florida
Florida Cancer Specialists
Fort Myers, Florida
Memorial Regional Cancer Center
Hollywood, Florida
Integrated Community Oncology Network
Jacksonville, Florida
Watson Clinic Center for Cancer Care and Research
Lakeland, Florida
Space Coast Medical Associates
Titusville, Florida
Piedmont Healthcare
Atlanta, Georgia
Emory/Winship Cancer Institute
Atlanta, Georgia
Augusta Oncology Associates
Augusta, Georgia
Medical Oncology Associates of Augusta
Augusta, Georgia
Medical College of Georgia Cancer Specialists
Augusta, Georgia
Northeast Georgia Medical Center
Gainesville, Georgia
Suburban Hem Onc
Lawrenceville, Georgia
Mid-Illinois Hematology & Oncology
Normal, Illinois
Hematology Oncology of the North Shore
Skokie, Illinois
Oncology Hematology Associates of SW Indiana
Evansville, Indiana
Hematology Oncology of Indiana
Indianapolis, Indiana
Providence Medical Group
Terre Haute, Indiana
Kansas City Cancer Centers
Overland Park, Kansas
Cotton O'Neil Cancer Center
Topeka, Kansas
Consultants in Blood Disorders and Cancer
Louisville, Kentucky
Baton Rouge General Medical Center
Baton Rouge, Louisiana
Mercy Hospital
Portland, Maine
Weinberg Cancer Institute at Franklin Square
Baltimore, Maryland
Center for Cancer and Blood Disorders
Bethesda, Maryland
Fallon Clinic
Worcester, Massachusetts
Grand Rapids Clinical Oncology Program
Grand Rapids, Michigan
Fairview Medical Oncology Clinic
Edina, Minnesota
St. Louis Cancer Care
Chesterfield, Missouri
Showing 40 of 70 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.